The 21st Century Cures Act established PRGLAC to advise the Secretary of Health and Human Services (HHS) regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. PRGLAC was tasked with identifying these gaps and reporting its findings back to the Secretary.
Federal members include the directors of NIH, NICHD, the Centers for Disease Control and Prevention, the HHS Office on Women's Health, and the Commissioner of Food and Drugs. Non-federal members include representatives from relevant medical societies, non-profit organizations, and industry.
- PRGLAC Report to the HHS Secretary and Congress, September 2018 (PDF 7 MB)
- List of Recommendations from the PRGLAC Report
- PRGLAC Report Implementation Plan (PDF 678 KB)
- August 21-22, 2017
- November 6-7, 2017
- February 26-27, 2018
- May 14-15, 2018
- May 22, 2019
- August 22-23, 2019
- February 3, 2020
- June 24, 2020
Aaron Pawlyk, Ph.D.
Obstetric and Pediatric Pharmacology and Therapeutics Branch Chief